Patent on meningitis bug
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.AN AMERICAN company has applied to patent one of the bacterias that causes meningitis, it was reported last night.
It could lead to royalties being paid on every treatment if a new vaccine against the illness in found.
Human Genome Sciences has filed the patent, which, if granted will open the door for commercial companies to patent any lifeform from which they think they can make money - including human gene sequences.
Scientists are appalled by the project because they believe discoveries should be shared for the common good.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments